Zobrazeno 1 - 10
of 35
pro vyhledávání: '"O. De Vita"'
Autor:
Michele Orditura, Andrea Mabilia, Eva Lieto, Marica Gemei, Gennaro Galizia, Margherita Pinto, o De Vita, Ciro Romano, Ferdin, Annamaria Auricchio, Anna Zamboli
Publikováno v:
Journal of Molecular Biomarkers & Diagnosis.
Recent findings suggested the presence in several cancers, comprising colorectal malignancies, of a small subset of tumor-initiating cells, or cancer stem cells. So the isolation and characterization of tumorigenic colorectal cancer cells was extreme
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M. Marconi, L. Janiri, L. De Risio, Giovanni Camardese, Giovanni Martinotti, Mauro Pettorruso, Angelo Bruschi, M. Di Nicola, F. Ruggeri, O. De Vita
Publikováno v:
European Neuropsychopharmacology. 23:S391-S392
Autor:
O. De Vita, Luigi Janiri, Daniela Tedeschi, M. Di Nicola, Daniele Stavros Hatzigiakoumis, Giovanni Martinotti, Gino Pozzi
Publikováno v:
European Psychiatry. 28:1
There is increasing consensus on the notion of addiction as a brain disorder characterized by longstanding changes in cognitive functioning, especially in so-called executive functions. Recent evidences indicate that specific components of executive
Autor:
O. De Vita, Giovanni Martinotti, I. Gualtieri, Daniele Stavros Hatzigiakoumis, M. Di Nicola, L. Janiri, Daniela Tedeschi, Riccardo Guglielmo, Marianna Quatrale, Gino Pozzi
Publikováno v:
European Neuropsychopharmacology. 22:S391
Publikováno v:
European Psychiatry. 27:1
There is increasing consensus on the notion of addiction as a brain disorder characterized by longstanding changes in cognitive functioning, especially in so-called executive functions. Recent evidences indicate that specific components of executive
Autor:
O. De Vita, Giovanni Martinotti, Daniele Stavros Hatzigiakoumis, Gino Pozzi, Luigi Janiri, Daniela Tedeschi, M. Di Nicola, M. Monetta
Publikováno v:
European Psychiatry. 27:1
Non-benzodiazepine anticonvulsant agents have been shown to be efficacious treatments for the prevention of alcohol relapse although the FDA has yet approved none of these agents. Several studies have demonstrated topiramate's efficacy in improving d